Sandy Van, Obesity Medicine Specialist and Chief Medical Officer, Hims & Hers Canada
A single documented case (Gordon et al., JAAD Case Reports 2024) showed a measurable improvement in hair density in a 57-year-old man with insulin resistance after twelve months on tirzepatide
Storage & Reconstitution Store lyophilized Retatrutide refrigerated at 28C for routine laboratory storage or at -20C for long-term preservation
Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial
Semaglutide and Tirzepatide are FDA-approved, clinically tested, non-stimulant, and non-habit forming